image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Al Noor Hospitals

June 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ANH
  • Price:
  • 1001p
The shares spiked to a new high of 1165p at one point ahead of a strong update, which noted sales rising 25% to US$111.6m in the first quarter to 28 April. The number of revenue generating physicians (its key proxy for future growth) increased by 32 in the quarter and by 132 year-on-year and the group remains on target to hire 70-80 in 2014 as a whole. In Q1 three new medical centres were commissioned. The centres at Bateen and Baniyas are in areas with significant Emirati populations while the ICAD medical centre is in an industrial workers residential facility. Al Noor remains debt free with US$63m cash and is still looking for more eps enhancing acquisitions. Jefferies expects eps of 76 cents (45.2p) this year and 90 c ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Al Noor Hospitals - VPS Healthcare and NMC could yet gatecrash agreed Mediclinic offer (December 2015)
Al Noor Hospitals - In merger talks (November 2015)
Al Noor Hospitals - Shares hit by director sale (June 2015)
Al Noor Hospitals - Shares hit new high (October 2014)
Al Noor Hospitals (April 2014)
Al Noor Hospitals - Third acquisition post float (February 2014)
Al Noor Hospitals - Makes its first two acquisitions (December 2013)
Al Noor Hospitals - Hospitals group forecast to grow eps 88% over next three years (October 2013)
AL Noor Hospitals - Exciting new issue in fast growing Middle East private health care market (August 2013)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X